Search Results - "McElfresh, Megan"

A comparative anatomical study of the human knee and six animal species by Proffen, Benedikt L, McElfresh, Megan, Fleming, Braden C, Murray, Martha M

“…Abstract Purpose Animal models are an indispensable tool for developing and testing new clinical applications regarding the treatment of acute injuries and…”
Get full text

Clinical Responses to CAR.CD30-T Cells in Patients with CD30+ Lymphomas Relapsed after Multiple Treatments Including Brentuximab Vedotin by Grover, Natalie S, Park, Steven I, Ivanova, Anastasia, Eldridge, Paul, McKay, Kathryn, Cheng, Catherine Joyce Arago, Laing, Spencer, Covington, Deborah, West, John, Sharf, S. Elizabeth, Morrison, J. Kaitlin, Scott, Shaw, Crecelius, Erin, Shelley, Desirae, Alexander, Maurice, Buchanan, Faith Brianne, Kassam, Emily Herrick, McElfresh, Megan, Pinto, Alicia R, Spruill, Angela Denise, Zanter, Ashley, Wehner, Kimberly, Dittus, Christopher, Shea, Thomas C., Dotti, Gianpietro, Serody, Jonathan S, Beaven, Anne, Savoldo, Barbara

“…Background: Infusion of chimeric antigen receptor modified T cells targeting the CD30 molecule and encoding the CD28 endodomain (CD30.CAR-Ts) in the absence of…”
Get full text

491 - Increasing Throughput in the BMT Clinic Setting by Davis, Rebecca, Riches, Marcie L., Sharf, Andrew, Sharf, S. Elizabeth, McElfresh, Megan, Stinson, Paula, Taylor, Kinley, Amos, Alison, Haithcox, Charlotte

Get full text

A Phase Ib/II Study of Anti-CD30 Chimeric Antigen Receptor T Cells for Relapsed/Refractory CD30+ Lymphomas by Grover, Natalie S., Park, Steven I., Ivanova, Anastasia, Eldridge, Paul, McKay, Kathryn, Cheng, Catherine, Laing, Spencer, Covington, Deborah, West, John, Sharf, Elizabeth, Morrison, J. Kaitlin, Scott, Shaw, Crecelius, Erin, Shelley, Desirae, Alexander, Maurice, Buchanan, Faith Brianne, Kassam, Emily, McElfresh, Megan, Pinto, Alicia, Spruill, Angela, Zanter, Ashley, Wehner, Kimberly, Dittus, Christopher, Shea, Thomas C., Dotti, Gianpietro, Serody, Jonathan S., Beaven, Anne, Savoldo, Barbara

“…Treatment with chimeric antigen receptor modified T cells targeting CD30 (CD30.CAR-Ts) without lymphodepletion was found to be safe with preliminary efficacy…”
Get full text

Increasing Throughput in the BMT Clinic Setting by Davis, Rebecca, Riches, Marcie L, Sharf, Andrew, Sharf, S. Elizabeth, McElfresh, Megan, Stinson, Paula, Taylor, Kinley, Amos, Alison, Haithcox, Charlotte

Get full text